| Verum (n = 18) | Placebo (n = 16) | V vs. P | |
---|---|---|---|---|
\( \overline{\mathrm{x}} \) ± SD | \( \overline{\mathrm{x}} \) ± SD | p -value | ||
sex (n) | f | 10 (56%) | 11 (69%) | 0.429a |
m | 8 (44%) | 5 (31%) | Â | |
Age (years) | 50 ± 9 | 50 ± 12 | 0.670b | |
Height (cm) | 172 ± 8 | 169 ± 10 | 0.313b | |
Weight (kg) | 83 ± 17 | 82 ± 19 | 0.772b | |
BMI (kg/m2) | 28.0 ± 4.4 | 28.3 ± 4.8 | 0.986b | |
≤24.5 kg/m2 | 5 (28%) | 3 (19%) | 0.825a | |
24.6-29.9Â kg/m2 | 8 (44%) | 8 (50%) | Â | |
≥30 kg/m2 | 5 (28%) | 5 (31%) |  | |
WC female (cm) | 88 ± 11 | 83 ± 11 | 0.197b | |
WC f ≥ 88 cm (n) | 7 (70%) | 3 (27%) | 0.050a | |
WC male (cm) | 100 ± 11 | 102 ± 17 | 0.524b | |
WC m ≥ 102 cm (n) | 4 (50%) | 3 (60%) | 0.725a | |
BP systolic (mmHg) | 135 ± 10 | 131 ± 13 | 0.175b | |
≥130 mmHgci | 14 (78%) | 6 (38%) | 0.017a | |
BP diastolic (mmHg) | 85 ± 10 | 83 ± 8 | 0.463b | |
≥85 mmHg | 9 (50%) | 8 (50%) | 1.000a | |
Pulse pressure | 51 ± 9 | 48 ± 10 | 0.313b | |
rHR (1/min) | 69 ± 10 | 73 ± 10 | 0.597b | |
PNF (points) | 41 ± 5 | 39 ± 6 | 0.229b | |
PN (points) | 16 ± 3 | 16 ± 4 | 0.873b | |
Impulsion (points) | 8 ± 2 | 7 ± 2 | 0.215b | |
Concentration (points) | 7 ± 3 | 7 ± 3 | 0.901b | |
Cortisol_m (ng/ml)c | 7.5 ± 4.4 | 6.1 ± 3.3 | 0.552b | |
Cortisol_e (ng/ml)c | 1.2 ± 1.5 | 1.2 ± 1.2 | 0.711b | |
ΔCortisol (ng/ml)c | 6.3 ± 5.0 | 5.0 ± 3.8 | 0.652b | |
Serotonin (μg/l)c | 180 ± 84 | 180 ± 47 | 0.444b | |
CRP sensitive (mg/l) | 2.9 ± 3.1 | 6.6 ± 7.9 | 0.202b | |
GGT (U/l) | 45 ± 48 | 21 ± 11 | 0.046b | |
TC (mg/dl) | 219 ± 36 | 217 ± 43 | 0.772b | |
HDL-C (mg/dl) | 59.0 ± 26.8 | 61.4 ± 18.0 | 0.356b | |
LDL-C (mg/dl) | 133 ± 34 | 132 ± 42 | 0.932b | |
LDL-C/HDL-C | 2.6 ± 1.0 | 2.3 ± 0.9 | 0.330b | |
TG (mg/dl) | 162 ± 88 | 145 ± 57 | 0.851b | |
TG/HDL-C | 3.4 ± 2.6 | 2.8 ± 1.8 | 0.621b | |
FPG (mg/dl) | 99 ± 28 | 97 ± 16 | 0.798b | |
HbA1c (%) | 5.8 ± 0.9 | 5.7 ± 0.3 | 0.330b | |
HOMA-Index | 3.2 ± 3.3 | 2.0 ± 1.2 | 0.330b | |
Insulin-ECLIA (μU/ml) | 11.9 ± 8.1 | 8.1 ± 4.1 | 0.266b |